AN1 0.00% 0.8¢ anagenics limited

Ann: Key Midkine Antibody Patents Granted in the US and Europe, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,143 Posts.
    lightbulb Created with Sketch. 350
    Hello Andrew

    "I do get the feeling that the last raise was a bit of a present for Maria and Dennis with the shares and options. I suspect they know full well what is coming and were just getting their final fill before lift off."

    That was my thoughts as well and they certainly took a chop at it and hence I followed as best i could.

    The other clue from Maria was the "negotiations intensified during the quarter". Perhaps i read too much into it. The raise to me seemed a little unnecessary under the heading of working capital.

    Well today's ann would be a key deal maker for any potential partner. The ann also went into a reasonable amount of detail on the breadth of the IP and duration of patents. Clearly leading commentary if ever I heard it.

    Clearly the dude who runs the bot is still on holidays so have to wait for their return to flick the switch to $2+ in the next months

    GLTA
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.